Description
Description: Soranib is a medication available in tablet form, containing the active ingredient Sorafenib. Sorafenib is a targeted therapy medication that works by inhibiting the growth and spread of cancer cells by blocking certain enzymes and receptors involved in cancer cell proliferation and angiogenesis (the formation of new blood vessels that support tumor growth).
Manufacturer: Soranib is manufactured by Cipla Ltd., a leading global pharmaceutical company known for its commitment to providing affordable and high-quality medications to patients worldwide.
Indications: Soranib is indicated for the treatment of certain types of cancers, including advanced renal cell carcinoma (kidney cancer), hepatocellular carcinoma (liver cancer), and thyroid cancer that has spread to other parts of the body. It may be used alone or in combination with other medications or treatments as prescribed by a healthcare professional.
Dosage and Administration: The dosage of Soranib (Sorafenib 200 Mg Tablets) and the duration of treatment are determined by a healthcare provider based on various factors, including the type and stage of cancer, the patient’s medical history, and response to treatment. The tablets are typically taken orally with water, either with or without food, as directed by the healthcare provider.
Precautions: Before using Soranib, patients should inform their healthcare provider about any medical conditions they have, especially liver or kidney problems. It’s crucial to disclose all medications, supplements, and herbal products being taken, as they may interact with Soranib and affect its efficacy or increase the risk of side effects.
Side Effects: Common side effects of Soranib may include diarrhea, nausea, vomiting, loss of appetite, fatigue, skin rash, hand-foot skin reaction (palmar-plantar erythrodysesthesia), high blood pressure, and changes in liver function tests. Serious side effects such as severe allergic reactions, bleeding, heart problems, and liver failure are rare but should be reported to a healthcare provider immediately.
Storage: Soranib should be stored as per the manufacturer’s instructions, typically at room temperature away from moisture and heat. It should be kept out of reach of children and disposed of properly according to local regulations.
Disclaimer: This information is provided for educational purposes and should not replace professional medical advice. Patients should consult their healthcare provider for personalized guidance regarding the use of Soranib (Sorafenib 200 Mg Tablets) and its potential benefits and risks.
Reviews
There are no reviews yet.